MoneyWorks4Me

Sequent Scientific informs about company updates

22 Sep 2018 Evaluate

Sequent Scientific has informed that the Company has entered into a Business transfer agreement with Solara Active Pharma Sciences Limited to acquire the EU-GMP API facility at Mahad (Mahad facility). The total consideration for the unit would be Rs 46.4 crores on an Enterprise Valuation basis. The acquired Mahad facility compliments the current manufacturing at Vizag (USFDA approved) and Tarapur (Intermediates).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..